PT3646881T - Composição para estimulação controlada do ovário - Google Patents

Composição para estimulação controlada do ovário

Info

Publication number
PT3646881T
PT3646881T PT192136497T PT19213649T PT3646881T PT 3646881 T PT3646881 T PT 3646881T PT 192136497 T PT192136497 T PT 192136497T PT 19213649 T PT19213649 T PT 19213649T PT 3646881 T PT3646881 T PT 3646881T
Authority
PT
Portugal
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
PT192136497T
Other languages
English (en)
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT3646881(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of PT3646881T publication Critical patent/PT3646881T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PT192136497T 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário PT3646881T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08

Publications (1)

Publication Number Publication Date
PT3646881T true PT3646881T (pt) 2021-06-02

Family

ID=46785372

Family Applications (6)

Application Number Title Priority Date Filing Date
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT192136497T PT3646881T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT18167552T PT3395357T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT212077176T PT4005588T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT17154031T PT3195875T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Family Applications After (4)

Application Number Title Priority Date Filing Date
PT18167552T PT3395357T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT14184409T PT2821080T (pt) 2011-08-08 2012-08-08 Composição para simulação de ovário controlada
PT201869351T PT3756681T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário
PT212077176T PT4005588T (pt) 2011-08-08 2012-08-08 Composição para estimulação controlada do ovário

Country Status (30)

Country Link
US (5) US9694052B2 (pt)
EP (9) EP4306174A3 (pt)
JP (5) JP6161609B2 (pt)
KR (8) KR102111514B1 (pt)
CN (2) CN107281470A (pt)
AR (1) AR087476A1 (pt)
AU (3) AU2012293647B2 (pt)
BR (2) BR122020001644B1 (pt)
CA (1) CA2844282A1 (pt)
CY (1) CY1117214T1 (pt)
DK (8) DK3566712T3 (pt)
ES (8) ES2742163T3 (pt)
FI (2) FI3756681T3 (pt)
HR (8) HRP20240420T1 (pt)
HU (8) HUE053716T2 (pt)
IL (2) IL300380A (pt)
JO (1) JO3092B1 (pt)
LT (7) LT3195875T (pt)
MX (5) MX348981B (pt)
PL (8) PL2741763T3 (pt)
PT (6) PT3195875T (pt)
RS (8) RS57897B1 (pt)
RU (2) RU2739037C3 (pt)
SA (1) SA112330762B1 (pt)
SI (8) SI3646881T1 (pt)
SM (1) SMT201600038B (pt)
TR (2) TR201911269T4 (pt)
TW (2) TWI657822B (pt)
WO (1) WO2013020996A1 (pt)
ZA (2) ZA201400952B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
EP3662925B1 (en) * 2015-04-17 2021-04-07 Ferring B.V. Composition comprising fsh for treatment of infertility
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
KR20180052128A (ko) * 2015-09-17 2018-05-17 글리코토페 게엠베하 증가된 안정성을 갖는 포유동물 난포-자극 호르몬 조성물
MA46353A (fr) * 2016-09-30 2019-08-07 Myovant Sciences Gmbh Méthodes de traitement de l'infertilité féminine
US11744879B2 (en) * 2017-09-01 2023-09-05 Ferring B.V. Recombinant FSH composition for controlled ovarian stimulation
RS66871B1 (sr) * 2018-04-30 2025-06-30 Ferring Bv Kompozicija za kontrolisanu stimulaciju jajnika
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
AU2023302100A1 (en) 2022-07-08 2025-01-02 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
ES2261740T3 (es) 2001-10-22 2006-11-16 Applied Research Systems Ars Holding N.V. Composiciones de fsh con alto grado de sialilacion y su uso para la preparacion de medicamentos.
US20040248784A1 (en) 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 菲瑞茵國際中心股份有限公司 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
DE102010007984B4 (de) 2010-02-15 2012-01-26 Hochland Ag Form- und Kühlvorrichtung für eine fließfähige, aufgeschmolzene Lebensmittelmasse
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
EP2621517B2 (en) * 2010-09-29 2023-10-11 Ferring B.V. Composition for use in treating infertility
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
EP4005588A1 (en) 2022-06-01
AU2012293647B2 (en) 2016-10-06
ES2884947T3 (es) 2021-12-13
JP6500050B2 (ja) 2019-04-10
EP2741763B1 (en) 2015-11-18
LT3646881T (lt) 2021-05-25
DK3646881T3 (da) 2021-07-26
HK1198005A1 (zh) 2015-03-06
DK3756681T3 (da) 2023-07-31
KR20230024442A (ko) 2023-02-20
JP6161609B2 (ja) 2017-07-12
DK4005588T3 (da) 2024-04-29
HUE041769T2 (hu) 2019-05-28
TW201309322A (zh) 2013-03-01
SA112330762B1 (ar) 2015-10-08
PT3756681T (pt) 2023-07-25
TR201911269T4 (tr) 2019-08-21
IL230696B2 (en) 2023-07-01
EP4306174A2 (en) 2024-01-17
KR20190100449A (ko) 2019-08-28
ES2704878T3 (es) 2019-03-20
AU2018203222B2 (en) 2020-03-12
SI2741763T1 (sl) 2016-02-29
TWI657822B (zh) 2019-05-01
US9694052B2 (en) 2017-07-04
HUE053716T2 (hu) 2021-07-28
HUE066158T2 (hu) 2024-07-28
HRP20160145T1 (hr) 2016-04-08
JP2020147600A (ja) 2020-09-17
KR102353144B1 (ko) 2022-01-18
SI2821080T1 (sl) 2019-01-31
ES2950911T3 (es) 2023-10-16
MX2020010991A (es) 2020-11-09
EP3395357A1 (en) 2018-10-31
HUE044610T2 (hu) 2019-11-28
ES2562648T3 (es) 2016-03-07
DK3566712T3 (da) 2021-04-19
HRP20230607T1 (hr) 2023-09-29
EP3646881A1 (en) 2020-05-06
MX2014001489A (es) 2014-04-25
NZ620369A (en) 2015-12-24
RU2739037C3 (ru) 2021-09-08
LT3566712T (lt) 2021-03-10
RU2014102924A (ru) 2015-09-20
PL2821080T3 (pl) 2019-04-30
IL230696B1 (en) 2023-03-01
KR20210099162A (ko) 2021-08-11
LT3395357T (lt) 2019-08-26
EP3195875B1 (en) 2018-07-25
PL2741763T3 (pl) 2016-07-29
ES2871405T3 (es) 2021-10-28
SI4005588T1 (sl) 2024-06-28
PL4005588T3 (pl) 2024-06-10
SI3646881T1 (sl) 2021-08-31
EP3646881B1 (en) 2021-04-28
HRP20210722T1 (hr) 2021-06-11
ES2692774T3 (es) 2018-12-05
AU2018203222A1 (en) 2018-05-24
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
RS57897B1 (sr) 2019-01-31
LT3756681T (lt) 2023-07-25
US20140329748A1 (en) 2014-11-06
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
CN103732243A (zh) 2014-04-16
RS61672B1 (sr) 2021-04-29
TWI555530B (zh) 2016-11-01
ZA201506382B (en) 2017-01-25
RU2017106756A3 (pt) 2020-07-09
US10624953B2 (en) 2020-04-21
ZA201400952B (en) 2022-03-30
DK4005588T5 (da) 2024-08-05
BR122020001644B1 (pt) 2022-08-02
RU2739037C2 (ru) 2020-12-21
EP3566712A1 (en) 2019-11-13
MX2024008825A (es) 2024-07-25
HK1204923A1 (en) 2015-12-11
BR112014002884A2 (pt) 2017-02-21
KR20200121918A (ko) 2020-10-26
HUE027674T2 (en) 2016-11-28
MX348981B (es) 2017-07-06
MX381278B (es) 2025-03-12
US20180028620A1 (en) 2018-02-01
SI3566712T1 (sl) 2021-04-30
EP3756681A1 (en) 2020-12-30
HUE054312T2 (hu) 2021-08-30
EP3195875A1 (en) 2017-07-26
IL230696A0 (en) 2014-03-31
ES2977682T3 (es) 2024-08-28
SMT201600038B (it) 2016-02-25
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
PT3195875T (pt) 2018-10-31
PT2821080T (pt) 2018-12-17
AU2016273925B2 (en) 2018-03-15
JP7309660B2 (ja) 2023-07-18
FI3756681T3 (fi) 2023-07-28
PL3566712T3 (pl) 2021-07-12
HUE040058T2 (hu) 2019-02-28
RU2017106756A (ru) 2019-01-23
CN107281470A (zh) 2017-10-24
JP2019077693A (ja) 2019-05-23
WO2013020996A1 (en) 2013-02-14
EP3395357B1 (en) 2019-05-15
TR201900071T4 (tr) 2019-01-21
KR102014469B1 (ko) 2019-08-26
HRP20210277T1 (hr) 2021-04-02
RU2613324C2 (ru) 2017-03-15
JP6718951B2 (ja) 2020-07-08
CY1117214T1 (el) 2017-04-05
HUE062640T2 (hu) 2023-11-28
CA2844282A1 (en) 2013-02-14
KR20250126867A (ko) 2025-08-25
RS58198B1 (sr) 2019-03-29
HRP20240420T1 (hr) 2024-06-21
EP3756681B1 (en) 2023-05-03
LT3195875T (lt) 2018-11-12
DK3756681T5 (da) 2024-08-26
LT2821080T (lt) 2019-01-10
RS64328B1 (sr) 2023-08-31
US20250302923A1 (en) 2025-10-02
KR102111514B1 (ko) 2020-05-18
DK3195875T3 (en) 2018-11-12
SI3756681T1 (sl) 2023-08-31
DK2821080T3 (en) 2019-01-28
PL3756681T3 (pl) 2023-08-21
HRP20190023T1 (hr) 2019-02-22
US20200345814A1 (en) 2020-11-05
HRP20181639T1 (hr) 2018-12-14
EP2821080A1 (en) 2015-01-07
KR20210143934A (ko) 2021-11-29
IL300380A (en) 2023-04-01
ES2742163T3 (es) 2020-02-13
EP3566712B1 (en) 2021-01-27
JO3092B1 (ar) 2017-03-15
PL3646881T3 (pl) 2021-11-02
PL3395357T3 (pl) 2019-11-29
JP2017141253A (ja) 2017-08-17
KR20190140098A (ko) 2019-12-18
TW201716082A (zh) 2017-05-16
PL3195875T3 (pl) 2019-01-31
AU2016273925A1 (en) 2017-01-12
JP7844394B2 (ja) 2026-04-13
EP4306174A3 (en) 2024-04-10
EP4005588B1 (en) 2024-02-07
AU2012293647A1 (en) 2014-02-27
RS59107B1 (sr) 2019-09-30
RS61843B1 (sr) 2021-06-30
US12478660B2 (en) 2025-11-25
AR087476A1 (es) 2014-03-26
SI3395357T1 (sl) 2019-09-30
RS54561B1 (sr) 2016-06-30
JP2014522871A (ja) 2014-09-08
PT3395357T (pt) 2019-08-27
KR102499969B1 (ko) 2023-02-14
MX2024008826A (es) 2024-07-25
DK3395357T3 (da) 2019-08-19
FI4005588T3 (fi) 2024-05-15
DK2741763T3 (da) 2016-02-15
HRP20191437T1 (hr) 2019-11-15
RU2613324C3 (ru) 2021-06-09
RS65485B1 (sr) 2024-05-31
US20220370567A1 (en) 2022-11-24
KR20140054191A (ko) 2014-05-08
JP2023134561A (ja) 2023-09-27

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika
IL258934B (en) A method of controlling fuel composition
EP2711011A4 (en) COMPOSITION CONTAINING PANAXADIOL
PT3566712T (pt) Composição para estimulação controlada do ovário
IL213610A0 (en) Composition for treating dermatological conditions
GB201101778D0 (en) Composition
GB201102177D0 (en) Composition
GB201100037D0 (en) Composition